Clinical Trial Update: Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer [Phase 3]

View source ↗

Summary

This Phase 3 trial comparing abarelix to goserelin plus bicalutamide in advanced or metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abarelix (abarelix)
• Goserelin (Goserelin)
• bicalutamide (bicalutamide)

Snippet

Sponsor: Speciality European Pharma Limited | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED